OII 240816 20.00C (OII240816C20000) Stock Options, News & Quotes

US OptionsDetailed Quotes

OII240816C20000

Watchlist

9.00
+2.20+32.35%

15min DelayClose Jul 25 15:59 ET

9.00High9.00Low

Intraday

5D
Daily

News

Q2 2024 Oceaneering International Inc Earnings Call
Yahoo Finance39minutes ago
Earnings Call Summary | Oceaneering International(OII.US) Q2 2024 Earnings Conference
moomoo AI17:40 ET · Conference Call
Oceaneering International, Inc. (OII) Q2 2024 Earnings Call Transcript
Earnings Call Transcripts15:19 ET
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga14:12 ET
Sector Update: Energy Stocks Gain in Thursday Afternoon Trading
MT Newswires13:49 ET
Oceaneering Price Target Maintained With a $34.00/Share by Benchmark
Dow Jones13:45 ET · Ratings

Comments

Moomoo AI

Feb 29 07:55

The modest level of insider ownership and lack of insider transactions in the last three months suggest alignment with shareholder interests. However, significant insider selling over the past year could be a red flag for investors.

Insiders At Oceaneering International Sold US$2.5m In Stock, Alluding To Potential Weakness

Moomoo AI

Jan 29 05:53

Oceaneering International, Inc.'s transition from loss to profitability justifies its strong share price gain. Despite slowing gains, the company's future financial health remains crucial for shareholders.

Oceaneering International (NYSE:OII) Delivers Shareholders Impressive 37% CAGR Over 3 Years, Surging 6.4% in the Last Week Alone

Moomoo AI

Jan 11 07:09

Oceaneering International's respectable ROE is overshadowed by its high debt level. Investors should consider the company's performance potential in less favorable credit markets. High ROE without debt typically indicates a high-quality business.

Did Oceaneering International, Inc. (NYSE:OII) Use Debt To Deliver Its ROE Of 13%?

Moomoo Breakfast US

Jun 10, 2022 07:20

Columns Today's pre-market stock movers: DOCU, BGNE, RBLX, SFIX and more

Gainers:
• $Cogent Biosciences(COGT.US)$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US)$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US)$ +6% (In reaction to earnings/guidance)
• $BeiGene(BGNE.US)$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...